• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ATX

AMPLIA THERAPEUTICS LIMITED - Announcements

0.00% ! 19.0¢
Market Cap $92.43M  !

Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development... Amplia Therapeutics Limited is an Australia-based clinical-stage, drug development company. The Company is focused on developing proprietary, orally available, small molecule Focal Adhesion Kinase (FAK) inhibitors as candidate drugs for the treatment of cancer and various fibrotic diseases. The Company's pipeline includes narmafotinib (AMP945) and AMP886. narmafotinib is a selective and potent inhibitor of FAK and is in clinical development for pancreatic cancer and advanced preclinical development for idiopathic pulmonary fibrosis (IPF). The Company's second pipeline drug, AMP886, inhibits FAK and inhibits two key disease drug targets (VEGFR3 and FLT3). This drug is being evaluated in preclinical models of cancer. Its fibrosis program uses its FAK inhibitors to block fibrosis and cell migration in cancers. Its cancer Program is directed at using its FAK inhibitors to block FAK activity in the cancer cells and the surrounding tissue and therefore block survival/proliferation signals.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Announcements



ATX Initial Director's Interest Notice - Dr. Robert Peach11/09/15 download Created with Sketch. 299.47KB
ATX Dr. Robert Peach Appointed as a Non-Executive Director02/09/15 download Created with Sketch. 219.18KB
ATX Change of Director's Interest Notice - Michael Quinn01/09/15 download Created with Sketch. 407.6KB
ATX Results of Meeting - AGM28/08/15 download Created with Sketch. 283.49KB
ATX Chairman's Address to Shareholders - AGM28/08/15 download Created with Sketch. 209.19KB
ATX Appendix 4C - June 15 Qtr Cash Flow ReportPRICE SENSITIVE30/07/15 download Created with Sketch. 442.01KB
ATX Notice of Annual General Meeting/Proxy Form24/07/15 download Created with Sketch. 696.98KB
ATX 2015 Bioshares Investment Summit Presentation20/07/15 download Created with Sketch. 1.43MB
ATX Annual Report to shareholders17/07/15 download Created with Sketch. 573.18KB
ATX Full Year Statutory Accounts - Year Ended 31 March 201519/06/15 download Created with Sketch. 861.19KB
ATX Preliminary Final Report - Year Ended 31 March 2015PRICE SENSITIVE28/05/15 download Created with Sketch. 163.28KB
ATX Becoming a substantial holder - Christopher Collins22/05/15 download Created with Sketch. 135.49KB
ATX Compassionate Use Program UpdatePRICE SENSITIVE20/05/15 download Created with Sketch. 209.82KB
ATX Change of Director's Interest Notice - Michael Quinn14/05/15 download Created with Sketch. 406.31KB
ATX Innate Joins MS Outcome Assessment Consortium04/05/15 download Created with Sketch. 204.8KB
ATX Appendix 4C - March 2015 QuarterlyPRICE SENSITIVE30/04/15 download Created with Sketch. 419.27KB
ATX Appendix 3B - Employee Options27/04/15 download Created with Sketch. 504.59KB
ATX Presentation 10th Neurotech Investing&Partnering Conference09/04/15 download Created with Sketch. 1.32MB
ATX Company Update on Recent Activities30/03/15 download Created with Sketch. 213.25KB
ATX Appendix 4C - Quarterly Cash Flow Report - Dec 14 QtrPRICE SENSITIVE29/01/15 download Created with Sketch. 408.2KB
ATX Compassionate Use Program Update12/12/14 download Created with Sketch. 206.55KB
ATX Half Yearly Report and AccountsPRICE SENSITIVE20/11/14 download Created with Sketch. 200.47KB
ATX Patient Dosing Commences and Appointment of Dr MansellPRICE SENSITIVE11/11/14 download Created with Sketch. 281.07KB
ATX Appendix 4C - September 2014 QuarterPRICE SENSITIVE31/10/14 download Created with Sketch. 168.67KB
ATX Appendix 3B - Employee Options24/10/14 download Created with Sketch. 504.56KB
ATX Update on Innate's Phase 2B trial and recent activitiesPRICE SENSITIVE07/10/14 download Created with Sketch. 383.22KB
ATX Change of Director's Interest Notice - S. Wilkinson18/09/14 download Created with Sketch. 401.97KB
ATX Appendix 3B - AGM approved Options to CEO18/09/14 download Created with Sketch. 504.94KB
ATX Results of Meeting - AGM21/08/14 download Created with Sketch. 284.5KB
ATX CEO Address to AGM20/08/14 download Created with Sketch. 1021.37KB
ATX Chairman's Address to Shareholders - AGM20/08/14 download Created with Sketch. 286.03KB
ATX Phase 2B WANRI Ethics Approval19/08/14 download Created with Sketch. 283.84KB
ATX Appendix 4C - June 2014 Quarterly Cash Flow ReportPRICE SENSITIVE29/07/14 download Created with Sketch. 417.57KB
ATX Use of Funds Consistent with Business Objectives21/07/14 download Created with Sketch. 199.08KB
ATX Annual Report to shareholders18/07/14 download Created with Sketch. 756.39KB
ATX Notice of Annual General Meeting/Proxy Form18/07/14 download Created with Sketch. 881.08KB
ATX Update on Phase 2B Trial of MIS416PRICE SENSITIVE20/06/14 download Created with Sketch. 203.29KB
ATX Compassionate Use Programme UpdatePRICE SENSITIVE18/06/14 download Created with Sketch. 207.18KB
ATX Full Year Statutory Accounts13/06/14 download Created with Sketch. 751.98KB
ATX Annual General Meeting to be held 20 August 201411/06/14 download Created with Sketch. 198.1KB
ATXPreliminary Final Report - Year Ended 31 March 2014PRICE SENSITIVE30/05/14 download Created with Sketch. 128.84KB
ATXSecurities Trading Policy20/05/14 download Created with Sketch. 396.49KB
ATXAppendix 4C - March 2014 Qtr Statement of Cash FlowsPRICE SENSITIVE30/04/14 download Created with Sketch. 467.95KB
ATXPhase 2B Trial on Track and on BudgetPRICE SENSITIVE15/04/14 download Created with Sketch. 204.29KB
ATXEU Radiation PatentPRICE SENSITIVE11/03/14 download Created with Sketch. 198.54KB
ATXResponse to ASX price and volume queryPRICE SENSITIVE07/03/14 download Created with Sketch. 342.39KB
ATXInvestor Roadshow Presentation03/02/14 download Created with Sketch. 1.86MB
ATXNewly Published MIS416 Therapy Validation in Animal StudiesPRICE SENSITIVE03/02/14 download Created with Sketch. 4.79MB
ATXAppendix 4C - Dec 2013 Quarterly Cash Flow StatementPRICE SENSITIVE31/01/14 download Created with Sketch. 465.77KB
AEF +Becoming a substantial holder from AEF07/01/14 download Created with Sketch. 68.4KB
ATXInitial Director's Interest Notice - Andrew Sneddon24/12/13 download Created with Sketch. 308.23KB
ATXInitial Director's Interest Notice - Elizabeth Hopkins24/12/13 download Created with Sketch. 305.38KB
ATXInitial Director's Interest Notice - Christopher Collins24/12/13 download Created with Sketch. 310.48KB
ATXInitial Director's Interest Notice - Simon Wilkinson24/12/13 download Created with Sketch. 310.72KB
ATXInitial Director's Interest Notice - Michael Quinn24/12/13 download Created with Sketch. 311.2KB
ATXConversion Offer Confirmation19/12/13 download Created with Sketch. 200.24KB
ATXCorporate Governance Compliance19/12/13 download Created with Sketch. 235.71KB
ATXRestricted Securities19/12/13 download Created with Sketch. 88.15KB
ATXSecurities Trading Policy19/12/13 download Created with Sketch. 185.05KB
ATXOld Employee Share Option Plan19/12/13 download Created with Sketch. 49.63KB
ATXNew Employee Share Option Plan19/12/13 download Created with Sketch. 69.72KB
ATXUpdated Statement of Commitments19/12/13 download Created with Sketch. 181.39KB
ATX2013 - Annual Report19/12/13 download Created with Sketch. 425.76KB
ATX2012 - Annual Report19/12/13 download Created with Sketch. 416.76KB
ATX2011 - Annual Report19/12/13 download Created with Sketch. 423.46KB
ATXUpdated Pro-forma Balance Sheet19/12/13 download Created with Sketch. 189.07KB
ATXConstitution19/12/13 download Created with Sketch. 232.08KB
ATXAppendix 1A and Information Form and Checklist19/12/13 download Created with Sketch. 216.42KB
ATXTop 20 Holders19/12/13 download Created with Sketch. 75.78KB
ATXDistribution Schedule19/12/13 download Created with Sketch. 43.93KB
ATXPre-Quotation Disclosure19/12/13 download Created with Sketch. 25.11KB
ATXASX Admission Circular19/12/13 download Created with Sketch. 44.03KB
ATXAdmission to Official ListPRICE SENSITIVE19/12/13 download Created with Sketch. 21.81KB
ATXInnate Immunotherapeutics Limited - Replacement Prospectus19/12/13 download Created with Sketch. 5.65MB
ATX Initial Director's Interest Notice - Dr. Robert Peach
11/09/15 download Created with Sketch. 299.47KB
ATX Dr. Robert Peach Appointed as a Non-Executive Director
02/09/15 download Created with Sketch. 219.18KB
ATX Change of Director's Interest Notice - Michael Quinn
01/09/15 download Created with Sketch. 407.6KB
ATX Results of Meeting - AGM
28/08/15 download Created with Sketch. 283.49KB
ATX Chairman's Address to Shareholders - AGM
28/08/15 download Created with Sketch. 209.19KB
ATX Appendix 4C - June 15 Qtr Cash Flow Report
30/07/15PRICE SENSITIVE download Created with Sketch. 442.01KB
ATX Notice of Annual General Meeting/Proxy Form
24/07/15 download Created with Sketch. 696.98KB
ATX 2015 Bioshares Investment Summit Presentation
20/07/15 download Created with Sketch. 1.43MB
ATX Annual Report to shareholders
17/07/15 download Created with Sketch. 573.18KB
ATX Full Year Statutory Accounts - Year Ended 31 March 2015
19/06/15 download Created with Sketch. 861.19KB
ATX Preliminary Final Report - Year Ended 31 March 2015
28/05/15PRICE SENSITIVE download Created with Sketch. 163.28KB
ATX Becoming a substantial holder - Christopher Collins
22/05/15 download Created with Sketch. 135.49KB
ATX Compassionate Use Program Update
20/05/15PRICE SENSITIVE download Created with Sketch. 209.82KB
ATX Change of Director's Interest Notice - Michael Quinn
14/05/15 download Created with Sketch. 406.31KB
ATX Innate Joins MS Outcome Assessment Consortium
04/05/15 download Created with Sketch. 204.8KB
ATX Appendix 4C - March 2015 Quarterly
30/04/15PRICE SENSITIVE download Created with Sketch. 419.27KB
ATX Appendix 3B - Employee Options
27/04/15 download Created with Sketch. 504.59KB
ATX Presentation 10th Neurotech Investing&Partnering Conference
09/04/15 download Created with Sketch. 1.32MB
ATX Company Update on Recent Activities
30/03/15 download Created with Sketch. 213.25KB
ATX Appendix 4C - Quarterly Cash Flow Report - Dec 14 Qtr
29/01/15PRICE SENSITIVE download Created with Sketch. 408.2KB
ATX Compassionate Use Program Update
12/12/14 download Created with Sketch. 206.55KB
ATX Half Yearly Report and Accounts
20/11/14PRICE SENSITIVE download Created with Sketch. 200.47KB
ATX Patient Dosing Commences and Appointment of Dr Mansell
11/11/14PRICE SENSITIVE download Created with Sketch. 281.07KB
ATX Appendix 4C - September 2014 Quarter
31/10/14PRICE SENSITIVE download Created with Sketch. 168.67KB
ATX Appendix 3B - Employee Options
24/10/14 download Created with Sketch. 504.56KB
ATX Update on Innate's Phase 2B trial and recent activities
07/10/14PRICE SENSITIVE download Created with Sketch. 383.22KB
ATX Change of Director's Interest Notice - S. Wilkinson
18/09/14 download Created with Sketch. 401.97KB
ATX Appendix 3B - AGM approved Options to CEO
18/09/14 download Created with Sketch. 504.94KB
ATX Results of Meeting - AGM
21/08/14 download Created with Sketch. 284.5KB
ATX CEO Address to AGM
20/08/14 download Created with Sketch. 1021.37KB
ATX Chairman's Address to Shareholders - AGM
20/08/14 download Created with Sketch. 286.03KB
ATX Phase 2B WANRI Ethics Approval
19/08/14 download Created with Sketch. 283.84KB
ATX Appendix 4C - June 2014 Quarterly Cash Flow Report
29/07/14PRICE SENSITIVE download Created with Sketch. 417.57KB
ATX Use of Funds Consistent with Business Objectives
21/07/14 download Created with Sketch. 199.08KB
ATX Annual Report to shareholders
18/07/14 download Created with Sketch. 756.39KB
ATX Notice of Annual General Meeting/Proxy Form
18/07/14 download Created with Sketch. 881.08KB
ATX Update on Phase 2B Trial of MIS416
20/06/14PRICE SENSITIVE download Created with Sketch. 203.29KB
ATX Compassionate Use Programme Update
18/06/14PRICE SENSITIVE download Created with Sketch. 207.18KB
ATX Full Year Statutory Accounts
13/06/14 download Created with Sketch. 751.98KB
ATX Annual General Meeting to be held 20 August 2014
11/06/14 download Created with Sketch. 198.1KB
ATXPreliminary Final Report - Year Ended 31 March 2014
30/05/14PRICE SENSITIVE download Created with Sketch. 128.84KB
ATXSecurities Trading Policy
20/05/14 download Created with Sketch. 396.49KB
ATXAppendix 4C - March 2014 Qtr Statement of Cash Flows
30/04/14PRICE SENSITIVE download Created with Sketch. 467.95KB
ATXPhase 2B Trial on Track and on Budget
15/04/14PRICE SENSITIVE download Created with Sketch. 204.29KB
ATXEU Radiation Patent
11/03/14PRICE SENSITIVE download Created with Sketch. 198.54KB
ATXResponse to ASX price and volume query
07/03/14PRICE SENSITIVE download Created with Sketch. 342.39KB
ATXInvestor Roadshow Presentation
03/02/14 download Created with Sketch. 1.86MB
ATXNewly Published MIS416 Therapy Validation in Animal Studies
03/02/14PRICE SENSITIVE download Created with Sketch. 4.79MB
ATXAppendix 4C - Dec 2013 Quarterly Cash Flow Statement
31/01/14PRICE SENSITIVE download Created with Sketch. 465.77KB
AEF +Becoming a substantial holder from AEF
07/01/14 download Created with Sketch. 68.4KB
ATXInitial Director's Interest Notice - Andrew Sneddon
24/12/13 download Created with Sketch. 308.23KB
ATXInitial Director's Interest Notice - Elizabeth Hopkins
24/12/13 download Created with Sketch. 305.38KB
ATXInitial Director's Interest Notice - Christopher Collins
24/12/13 download Created with Sketch. 310.48KB
ATXInitial Director's Interest Notice - Simon Wilkinson
24/12/13 download Created with Sketch. 310.72KB
ATXInitial Director's Interest Notice - Michael Quinn
24/12/13 download Created with Sketch. 311.2KB
ATXConversion Offer Confirmation
19/12/13 download Created with Sketch. 200.24KB
ATXCorporate Governance Compliance
19/12/13 download Created with Sketch. 235.71KB
ATXRestricted Securities
19/12/13 download Created with Sketch. 88.15KB
ATXSecurities Trading Policy
19/12/13 download Created with Sketch. 185.05KB
ATXOld Employee Share Option Plan
19/12/13 download Created with Sketch. 49.63KB
ATXNew Employee Share Option Plan
19/12/13 download Created with Sketch. 69.72KB
ATXUpdated Statement of Commitments
19/12/13 download Created with Sketch. 181.39KB
ATX2013 - Annual Report
19/12/13 download Created with Sketch. 425.76KB
ATX2012 - Annual Report
19/12/13 download Created with Sketch. 416.76KB
ATX2011 - Annual Report
19/12/13 download Created with Sketch. 423.46KB
ATXUpdated Pro-forma Balance Sheet
19/12/13 download Created with Sketch. 189.07KB
ATXConstitution
19/12/13 download Created with Sketch. 232.08KB
ATXAppendix 1A and Information Form and Checklist
19/12/13 download Created with Sketch. 216.42KB
ATXTop 20 Holders
19/12/13 download Created with Sketch. 75.78KB
ATXDistribution Schedule
19/12/13 download Created with Sketch. 43.93KB
ATXPre-Quotation Disclosure
19/12/13 download Created with Sketch. 25.11KB
ATXASX Admission Circular
19/12/13 download Created with Sketch. 44.03KB
ATXAdmission to Official List
19/12/13PRICE SENSITIVE download Created with Sketch. 21.81KB
ATXInnate Immunotherapeutics Limited - Replacement Prospectus
19/12/13 download Created with Sketch. 5.65MB
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
Add to My Watchlist
(20min delay)
Last
19.0¢
Change
0.000(0.00%)
Mkt cap ! $92.43M
Open High Low Value Volume
19.5¢ 19.5¢ 18.5¢ $220.8K 1.177M

Buyers (Bids)

No. Vol. Price($)
1 15000 18.5¢
 

Sellers (Offers)

Price($) Vol. No.
19.0¢ 205449 7
View Market Depth
Last trade - 16.10pm 12/08/2025 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.